Video Experimental Relacionado
Updated: Jul 8, 2026
14:27
Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
Published on: June 26, 2013
Sinergia cerebral dinámica descubre coordinación neuronal funcional en la enfermedad de Parkinson bajo modulación
Jiewei Lu1,2,3, Yuanyuan Cheng4, Xinyuan Zhang1
1College of Artificial Intelligence, Nankai University, Tianjin, 300350, People's Republic of China.
Journal of neuroengineering and rehabilitation
|January 31, 2026
Resumen
La sinergia cerebral dinámica, una medida novedosa, se normalizó con el tratamiento de la enfermedad de Parkinson. Este enfoque ofrece nuevos biomarcadores para el diagnóstico temprano y la terapia personalizada, a diferencia de los métodos tradicionales de conectividad funcional.
Área de la Ciencia:
- Neurociencia
- Neurociencia de Sistemas
- Neurociencia Computacional
Sus antecedentes:
- La sinergia y la redundancia cerebral ofrecen información sobre las funciones neuronales más allá de la conectividad funcional (FC) tradicional.
- Estos aspectos neuronales de orden superior siguen sin explorarse en la enfermedad de Parkinson (EP).
- El análisis dinámico es crucial para investigar los sustratos neuronales de la EP.
Objetivo del estudio:
- Investigar la sinergia y la redundancia cerebral dinámica en la enfermedad de Parkinson.
- Explorar el impacto del tratamiento dopaminérgico en estas dinámicas neuronales.
- Evaluar el potencial de la sinergia y la redundancia dinámicas como biomarcadores para la EP.
Principales métodos:
- Se desarrolló un marco de descomposición dinámica de la información para cuantificar la sinergia y la redundancia cerebral.
- Se aplicó el marco a datos de espectroscopia funcional de infrarrojo cercano (fNIRS) en estado de marcha.
- Se analizaron datos de 63 pacientes con EP en tratamiento dopaminérgico y 36 controles sanos.
Principales resultados:
- Los niveles de sinergia cerebral dinámica se restauraron a la normalidad tras el tratamiento dopaminérgico en pacientes con EP.
- La conectividad funcional (FC) dinámica tradicional mostró una información limitada de orden superior y una modulación insignificante del tratamiento.
- La redundancia cerebral dinámica exhibió variaciones insignificantes en respuesta al tratamiento dopaminérgico.
Conclusiones:
- La sinergia cerebral dinámica proporciona una perspectiva avanzada sobre las dinámicas neuronales en la EP.
- Esta medida promete descubrir biomarcadores funcionales de orden superior para la EP.
- Las aplicaciones potenciales incluyen el diagnóstico temprano y las estrategias de tratamiento individualizadas para la enfermedad de Parkinson.
Videos de Conceptos Relacionados
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
01:19Brainstem
The brainstem, located inferior to the brain and superior to the spinal cord, serves as a bridge between the cerebrum and the spinal cord. It plays a vital role in relaying information and controlling critical life functions. It comprises three primary regions: the midbrain, pons, and medulla oblongata.
The Midbrain
The midbrain is located beneath the diencephalon and connects the cerebrum with the lower parts of the brain. The cerebral peduncles are prominent midbrain structures that house the...
The Midbrain
The midbrain is located beneath the diencephalon and connects the cerebrum with the lower parts of the brain. The cerebral peduncles are prominent midbrain structures that house the...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...